Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
免疫抑制寡核苷酸的作用机制和治疗用途
基本信息
- 批准号:7733284
- 负责人:
- 金额:$ 37.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AcuteAntigensAutoimmunityBreathingCellsChronicDNADevelopmentDiseaseFrequenciesGoalsGrowthImmuneImmune responseImmunosuppressive AgentsInflammationInflammatoryInflammatory ResponseInjuryInvestigationLifeLigandsMalignant NeoplasmsMalignant neoplasm of lungMediatingMicroarray AnalysisModelingMorbidity - disease rateMusOligonucleotidesPapillomaPatternPredispositionPreventionRangeRegulator GenesResearchResearch DesignSeptic ShockSilicon DioxideSilicosisSkin CancerTherapeuticTissuescell typecellular targetingin vivoinformation gatheringinsightmortalityprogramsreceptorresponsetumoruptake
项目摘要
Synthetic oligonucleotides (ODN) expressing repetitive TTAGGG motifs patterned after hexameric sequences present at high frequency in mammalian teleomeres down-regulate the inflammatory immune responses elicited by a broad range of TLR ligands and the adaptive immune cell responses induced by polyclonal activators and antigens. These suppressive ODN are useful in the treatment of diseases characterized by over-exuberant immune responses, including septic shock and autoimmunity. Our recent studies demonstrate that suppressive ODN are also useful in the prevention/treatment of the life-threatening inflammation caused by silica inhalation (acute silicosis). Specifically, suppressive ODN treatment was shown to significantly reduce silica-induced mortality and morbidity. Despite this progress, very little is known about the cellular targets of suppressive ODN, the receptors responsible for their recognition/uptake, or their mechanism of action. We are using microarray technology to identify the genes and regulatory networks that enable suppressive ODN to disrupt ongoing inflammatory responses and determine the duration of their immuno-inhibitory activity in vivo. With the insight gained from these studies, we plan to identify the receptor(s) responsible for the recognition of the TTAGGG motif key to this suppressive activity. Information gathered on the targets and mechanism(s) of action of suppressive ODN will support studies designed to explore their therapeutic utility. Recent results suggest that systemically administered suppressive ODN can alter the hosts immune milieu, an effect being harnessed to reduce host susceptibility to inflammation-induced cancers. Two lines of investigation have been initiated to achieve this goal. First, the effect of suppressive ODN in a murine model of chemically-induced skin cancer is being evaluated. Preliminary evidence indicates that ODN impact the frequency and growth of chemically induced papillomas. Second, studies examining the effect of suppressive ODN in chronic silicosis, and the attendant development of lung cancer, have been initiated. It is hoped that the therapeutic utility of suppressive ODN identified through these research program can be harnessed to significantly reduce host susceptibility to tumor development and progression.
表达重复TTAGGG基序的合成寡核苷酸(ODN), 在哺乳动物端粒中以高频率存在的六聚体序列下调 由广泛的TLR配体和适应性免疫引起的炎症免疫应答 由多克隆活化剂和抗原诱导的细胞应答。这些抑制性ODN是有用的 用于治疗以过度旺盛的免疫应答为特征的疾病,包括 感染性休克和自身免疫我们最近的研究表明,抑制性ODN也 可用于预防/治疗由二氧化硅引起的危及生命的炎症 吸入(急性硅肺)。具体地说,抑制性ODN治疗显示, 显著降低二氧化硅引起死亡率和发病率。尽管取得了这些进展,但 关于抑制性ODN的细胞靶点,即负责 它们的识别/吸收,或它们的作用机制。我们用微阵列技术 确定基因和调控网络,使抑制性ODN破坏正在进行的 炎症反应,并确定其体内免疫抑制活性的持续时间。 通过这些研究获得的见解,我们计划确定负责的受体 用于识别TTAGGG基序,该基序是这种抑制活性的关键。收集的信息 关于抑制性ODN作用的靶点和机制的研究将支持旨在 探索它们的治疗效用最近的研究结果表明,全身给药 抑制性ODN可以改变宿主的免疫环境,这种作用被用来减少宿主的免疫应答。 易患炎症诱发的癌症。两条调查线已经启动 来实现这一目标。第一,抑制性ODN在小鼠模型中的作用, 正在评估化学诱导的皮肤癌。初步证据显示, 影响化学诱导的乳头状瘤的频率和生长。第二,研究 抑制性ODN在慢性矽肺中的作用及其对肺发育的影响 癌症已经开始。希望抑制性ODN的治疗效用 通过这些研究计划确定可以利用,以显着减少主机 对肿瘤发展和进展的易感性。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of CpG oligonucleotides on vaccine-induced B cell memory.
- DOI:10.4049/jimmunol.181.8.5785
- 发表时间:2008-10-15
- 期刊:
- 影响因子:0
- 作者:Tross D;Klinman DM
- 通讯作者:Klinman DM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dennis Klinman其他文献
Dennis Klinman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dennis Klinman', 18)}}的其他基金
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
免疫抑制寡核苷酸的作用机制和治疗用途
- 批准号:
8552865 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
刺激性 CpG 寡核苷酸的作用机制和治疗用途
- 批准号:
9153697 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
免疫抑制寡核苷酸的作用机制和治疗用途
- 批准号:
10014472 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
免疫刺激性 CpG 寡核的作用机制和治疗用途
- 批准号:
8552864 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
刺激性 CpG 寡核苷酸的作用机制和治疗用途
- 批准号:
9556390 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
免疫刺激性 CpG 寡核的作用机制和治疗用途
- 批准号:
7965763 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
免疫抑制寡核苷酸的作用机制和治疗用途
- 批准号:
7593000 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
免疫抑制寡核苷酸的作用机制和治疗用途
- 批准号:
8763253 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
刺激性 CpG 寡核苷酸的作用机制和治疗用途
- 批准号:
9343728 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
刺激性 CpG 寡核苷酸的作用机制和治疗用途
- 批准号:
8763252 - 财政年份:
- 资助金额:
$ 37.5万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Autoimmunity to LINE-1-encoded antigens in SLE pathogenesis
SLE 发病机制中对 LINE-1 编码抗原的自身免疫
- 批准号:
9908850 - 财政年份:2020
- 资助金额:
$ 37.5万 - 项目类别:
Establishment of murine models of myositis depending on autoimmunity to dermatomyositis-specific antigens
基于皮肌炎特异性抗原自身免疫的小鼠肌炎模型的建立
- 批准号:
18K08263 - 财政年份:2018
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Autoimmunity Against Novel Antigens in Neuropsychiatric Dysfunction
神经精神功能障碍中针对新抗原的自身免疫
- 批准号:
8658474 - 财政年份:2011
- 资助金额:
$ 37.5万 - 项目类别:
Autoimmunity Against Novel Antigens in Neuropsychiatric Dysfunction
神经精神功能障碍中针对新抗原的自身免疫
- 批准号:
8179641 - 财政年份:2011
- 资助金额:
$ 37.5万 - 项目类别:
Autoimmunity Against Novel Antigens in Neuropsychiatric Dysfunction
神经精神功能障碍中针对新抗原的自身免疫
- 批准号:
8307781 - 财政年份:2011
- 资助金额:
$ 37.5万 - 项目类别:
Autoimmunity Against Novel Antigens in Neuropsychiatric Dysfunction
神经精神功能障碍中针对新抗原的自身免疫
- 批准号:
8525457 - 财政年份:2011
- 资助金额:
$ 37.5万 - 项目类别:
Autoimmunity caused by T cells recognizing tissue restricted antigens with low avidity
T 细胞识别低亲合力组织限制性抗原引起的自身免疫
- 批准号:
37945399 - 财政年份:2007
- 资助金额:
$ 37.5万 - 项目类别:
Research Fellowships
Antigens of the RNA-induced silencing complex in autoimmunity
自身免疫中RNA诱导的沉默复合物的抗原
- 批准号:
7336803 - 财政年份:2001
- 资助金额:
$ 37.5万 - 项目类别:
Antigens of the RNA-induced silencing complex in autoimmunity
自身免疫中RNA诱导的沉默复合物的抗原
- 批准号:
7560044 - 财政年份:2001
- 资助金额:
$ 37.5万 - 项目类别:
Antigens of the RNA-induced silencing complex in autoimmunity
自身免疫中RNA诱导的沉默复合物的抗原
- 批准号:
7740863 - 财政年份:2001
- 资助金额:
$ 37.5万 - 项目类别: